HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Preclinical activity of the repurposed drug auranofin in classical Hodgkin lymphoma.

AuthorsMarta Celegato, Cinzia Borghese, Naike Casagrande, Maurizio Mongiat, Xaver U Kahle, Alice Paulitti, Michele Spina, Alfonso Colombatti, Donatella Aldinucci
JournalBlood (Blood) Vol. 126 Issue 11 Pg. 1394-7 (Sep 10 2015) ISSN: 1528-0020 [Electronic] United States
PMID26228484 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Auranofin
Topics
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Apoptosis (drug effects)
  • Auranofin (therapeutic use)
  • Cell Line, Tumor
  • Drug Resistance, Neoplasm
  • Drug Screening Assays, Antitumor
  • Female
  • Hodgkin Disease (drug therapy, metabolism, pathology)
  • Humans
  • Mice
  • Mice, Nude
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: